Nephrogenic Systemic Fibrosis Risk and Liver Disease

Objective. Evaluate the incidence of nephrogenic systemic fibrosis (NSF) in patients with liver disease in the peritransplant period. Materials and Methods. This IRB approved study retrospectively reviewed patients requiring transplantation for cirrhosis, hepatocellular carcinoma (HCC), or both from...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hanna, Robert F., Finkelstone, Lee A., Chow, Daniel S., Miloushev, Vesselin Z., Escudero, Mark R., Lagana, Stephen M., Prince, Martin R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2014
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3981185/
https://ncbi.nlm.nih.gov/pubmed/24778878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/679605
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak